Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the Colon Cancer Family Registry.

Genetic variants in the calcium/vitamin D metabolic pathway may be related to risk for colorectal cancer. While several investigations of vitamin D receptor (VDR) polymorphisms and colorectal cancer have been conducted, no studies to date have evaluated the association of genetic variation in the heterodimer partner for VDR, the retinoid X receptor (RXR). Another important gene in this pathway is the calcium-sensing receptor (CASR). Employing a discordant-sibship case-control design, we examined the association between single nucleotide polymorphisms (SNPs) in RXRA and CASR and risk for colorectal cancer overall and by colorectal subsite and microsatellite instability (MSI) status using data from the Colon Cancer Family Registry. No gene-level relationships between RXRA or CASR and colorectal cancer overall were observed. However, for RXRA SNP rs7861779, a high-interest SNP selected for study a priori, there was a statistically significantly increased risk for proximal colorectal cancer among those with at least one A allele [odds ratio (OR) = 1.42; 95% confidence interval (CI) = 1.03-1.97]. Another selected RXRA SNP, rs12004589, was significantly associated with risk of MSI-high cancers (OR = 2.27; 95% CI = 1.13-4.56). Additionally, CASR SNP rs1801726 was significantly associated with a reduced risk for rectal cancer (OR = 0.53; 95% CI = 0.29-0.96). These results provide support that RXRA SNPs rs7861779 and rs12004589 and CASR SNP rs1801726 may be important markers for colorectal neoplasia. Further work is needed to elucidate their role in the carcinogenic pathway.

[1]  David V Conti,et al.  Genetic polymorphisms in vitamin D receptor VDR/RXRA influence the likelihood of colon adenoma recurrence. , 2010, Cancer research.

[2]  J. Potter,et al.  Genetic Variation in the Vitamin D Receptor (VDR) and the Vitamin D–Binding Protein (GC) and Risk for Colorectal Cancer: Results from the Colon Cancer Family Registry , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[3]  R. Bostick,et al.  Effects of Vitamin D and Calcium on Proliferation and Differentiation In Normal Colon Mucosa: a Randomized Clinical Trial , 2009, Cancer Epidemiology, Biomarkers & Prevention.

[4]  F. Clavel-Chapelon,et al.  Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. , 2009, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[5]  R. Hayes,et al.  Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. , 2009, Carcinogenesis.

[6]  E. Brown,et al.  The role of the calcium-sensing receptor in the development and progression of cancer. , 2009, Endocrine reviews.

[7]  R. Bostick,et al.  Effects of Vitamin D and Calcium Supplementation on Markers of Apoptosis in Normal Colon Mucosa: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial , 2009, Cancer Prevention Research.

[8]  E. Hitre,et al.  Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population , 2008, BMC Cancer.

[9]  Peter W. Laird,et al.  Molecular Characterization of MSI-H Colorectal Cancer by MLHI Promoter Methylation, Immunohistochemistry, and Mismatch Repair Germline Mutation Screening , 2008, Cancer Epidemiology Biomarkers & Prevention.

[10]  C. Ulrich,et al.  Genetic Variation in Calcium-Sensing Receptor and Risk for Colon Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[11]  M. Haussler,et al.  Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. , 2008, Nutrition reviews.

[12]  W. Grady,et al.  Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.

[13]  C. Davis Vitamin D and cancer: current dilemmas and future research needs. , 2008, The American journal of clinical nutrition.

[14]  P. Holt New insights into calcium, dairy and colon cancer. , 2008, World journal of gastroenterology.

[15]  Bingshu E. Chen,et al.  Polymorphism of genes related to insulin sensitivity and the risk of biliary tract cancer and biliary stone: a population-based case–control study in Shanghai, China , 2008, Carcinogenesis.

[16]  M. Lane,et al.  Retinol Increases β-Catenin-RXRα Binding Leading to the Increased Proteasomal Degradation of β-Catenin and RXRα , 2007, Nutrition and cancer.

[17]  M. Boehnke,et al.  So many correlated tests, so little time! Rapid adjustment of P values for multiple correlated tests. , 2007, American journal of human genetics.

[18]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[19]  L. R. Howe Rexinoids and Breast Cancer Prevention , 2007, Clinical Cancer Research.

[20]  E. Jacobs,et al.  Diet, gender, and colorectal neoplasia. , 2007, Journal of clinical gastroenterology.

[21]  B. Necela,et al.  Differential expression, distribution, and function of PPAR-γ in the proximal and distal colon , 2007 .

[22]  David V Conti,et al.  Testing association between disease and multiple SNPs in a candidate gene , 2007, Genetic epidemiology.

[23]  I. Weinstein,et al.  Synergistic effects of RXR&agr; and PPAR&ggr; ligands to inhibit growth in human colon cancer cells—phosphorylated RXR&agr; is a critical target for colon cancer management , 2007, Gut.

[24]  Matthias Platzer,et al.  SNPSplicer: systematic analysis of SNP‐dependent splicing in genotyped cDNAs , 2006, Human mutation.

[25]  W. Lamph,et al.  Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer. , 2006, Cancer letters.

[26]  S. Gabriel,et al.  Efficiency and power in genetic association studies , 2005, Nature Genetics.

[27]  E. Jacobs,et al.  Vitamin D Activity and Colorectal Neoplasia: A Pathway Approach to Epidemiologic Studies , 2005, Cancer Epidemiology Biomarkers & Prevention.

[28]  P. Morel,et al.  Two colons‐two cancers: Paradigm shift and clinical implications , 2004, Journal of surgical oncology.

[29]  P. Lakatos,et al.  Relationship between serum calcium and CA 19-9 levels in colorectal cancer. , 2004, World journal of gastroenterology.

[30]  Toshihiro Tanaka The International HapMap Project , 2003, Nature.

[31]  Naisyin Wang,et al.  Chemopreventive n-3 fatty acids activate RXRα in colonocytes , 2003 .

[32]  R. Chandraratna,et al.  Adenomatous Polyposis Coli (APC)-independent Regulation of β-Catenin Degradation via a Retinoid X Receptor-mediated Pathway* , 2003, Journal of Biological Chemistry.

[33]  S. Humphries,et al.  The 4830C>A polymorphism within intron 5 affects the pattern of alternative splicing occurring within exon 6 of the thrombopoietin gene. , 2003, Experimental hematology.

[34]  G. Hendy,et al.  Human Calcium-sensing Receptor Gene , 2002, The Journal of Biological Chemistry.

[35]  B. Ohlsson,et al.  The Expression of Retinoic Acid Receptors and the Effects in Vitro by Retinoids in Human Pancreatic Cancer Cell Lines , 2002, Pancreas.

[36]  R. Evans,et al.  Nuclear receptors and lipid physiology: opening the X-files. , 2001, Science.

[37]  H. Harn,et al.  Expression of nuclear retinoid receptors in normal, premalignant and malignant gastric tissues determined by in situ hybridization , 1999, British Journal of Cancer.

[38]  G. Isshiki,et al.  Two mutations remote from an exon/intron junction in the β-hexosaminidase β-subunit gene affect 3’-splice site selection and cause Sandhoff disease , 1998, Human Genetics.

[39]  P. Chambon,et al.  Retinoic Acid Receptors Interact Physically and Functionally with the T:G Mismatch-specific Thymine-DNA Glycosylase* , 1998, The Journal of Biological Chemistry.

[40]  M. Langman,et al.  Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. , 1996, Cancer research.

[41]  B. Necela,et al.  Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon. , 2007, Physiological genomics.

[42]  I. Weinstein,et al.  Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management. , 2007, Gut.

[43]  Naisyin Wang,et al.  Chemopreventive n-3 fatty acids activate RXRalpha in colonocytes. , 2003, Carcinogenesis.

[44]  A. Tislér,et al.  Calcium-sensing receptor A986S polymorphism in human rectal cancer , 2002, International Journal of Colorectal Disease.

[45]  ummers,et al.  CALCIUM SUPPLEMENTS FOR THE PREVENTION OF COLORECTAL ADENOMAS , 2000 .

[46]  G. Isshiki,et al.  Two mutations remote from an exon/intron junction in the beta-hexosaminidase beta-subunit gene affect 3'-splice site selection and cause Sandhoff disease. , 1998, Human Genetics.

[47]  S Greenland,et al.  Re: "The impact of confounder selection criteria on effect estimation. , 1989, American journal of epidemiology.